Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$209.01 - $232.56 $31,142 - $34,651
149 Added 0.23%
63,991 $14 Million
Q4 2023

Jan 11, 2024

BUY
$197.69 - $227.29 $10,279 - $11,819
52 Added 0.08%
63,842 $14.5 Million
Q3 2023

Mar 07, 2024

SELL
$201.05 - $221.7 $4.22 Million - $4.65 Million
-20,979 Reduced 24.75%
63,790 $12.8 Million
Q3 2023

Oct 17, 2023

SELL
$201.05 - $221.7 $4.22 Million - $4.65 Million
-20,979 Reduced 24.75%
63,790 $12.8 Million
Q2 2023

Mar 07, 2024

BUY
$211.93 - $241.33 $259,190 - $295,146
1,223 Added 1.46%
84,769 $20.5 Million
Q2 2023

Jul 11, 2023

BUY
$211.93 - $241.33 $259,190 - $295,146
1,223 Added 1.46%
84,769 $20.5 Million
Q1 2023

Mar 07, 2024

BUY
$213.32 - $257.83 $4.2 Million - $5.08 Million
19,704 Added 30.86%
83,546 $19.2 Million
Q1 2023

Apr 18, 2023

BUY
$213.32 - $257.83 $273,689 - $330,795
1,283 Added 1.56%
83,546 $19.2 Million
Q4 2022

Jan 18, 2023

SELL
$203.72 - $248.97 $94,118 - $115,024
-462 Reduced 0.56%
82,263 $0
Q3 2022

Oct 12, 2022

BUY
$204.81 - $262.19 $16.9 Million - $21.7 Million
82,725 New
82,725 $16.9 Million
Q2 2022

Aug 08, 2022

BUY
$213.86 - $277.87 $17.7 Million - $23 Million
82,830 New
82,830 $19.4 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $798,686 - $916,605
3,074 Added 3.92%
81,523 $21.5 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $904,971 - $1.05 Million
-3,332 Reduced 4.07%
78,449 $24.6 Million
Q3 2021

Nov 17, 2021

BUY
$274.82 - $308.34 $1.31 Million - $1.47 Million
4,779 Added 6.21%
81,781 $23 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $3.28 Million - $3.62 Million
13,032 Added 20.37%
77,002 $21.2 Million
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $21,922 - $27,288
-107 Reduced 0.17%
63,970 $16.3 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $5,046 - $5,789
27 Added 0.04%
64,077 $13 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $2,839 - $3,422
-17 Reduced 0.03%
64,050 $12.1 Million
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $247,582 - $398,631
2,185 Added 3.53%
64,067 $10.6 Million
Q1 2020

May 13, 2020

BUY
$104.32 - $195.28 $1.14 Million - $2.13 Million
10,929 Added 21.45%
61,882 $7.82 Million
Q4 2019

Feb 13, 2020

BUY
$163.48 - $173.61 $40,870 - $43,402
250 Added 0.49%
50,953 $8.62 Million
Q3 2019

Nov 15, 2019

BUY
$159.77 - $178.1 $121,105 - $134,999
758 Added 1.52%
50,703 $8.52 Million
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $7.31 Million - $8.77 Million
-50,700 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $337,082 - $425,917
2,725 Added 5.68%
50,700 $15.2 Million
Q4 2018

Feb 14, 2019

BUY
$120.82 - $174.09 $58,597 - $84,433
485 Added 1.02%
47,975 $6.06 Million
Q3 2018

Nov 15, 2018

BUY
$167.67 - $188.27 $6,706 - $7,530
40 Added 0.08%
47,490 $8.25 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $38,479 - $45,458
240 Added 0.51%
47,450 $8.52 Million
Q1 2018

May 11, 2018

BUY
$161.53 - $178.11 $2.53 Million - $2.78 Million
15,635 Added 49.52%
47,210 $7.64 Million
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $2,959 - $3,279
-20 Reduced 0.06%
31,575 $5.04 Million
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $4.72 Million - $5.07 Million
31,595
31,595 $4.77 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Willis Investment Counsel Portfolio

Follow Willis Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.